The St. Jude Medical cardiac valve prosthesis: Long-term follow up of patients having double valve replacement

Journal of Heart Valve Disease

Volumn 16, Issue 6, 2007, Pages 634-640

  Emery, Robert W ^a,b   Emery, Ann M ^a   Krogh, Christopher ^a   Shake, Jay G ^a   Holter, Arlen R ^a   Blake, David P ^a   Raikar, Goya V ^a  

^a Cardiac Surgical Associates Florida   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ADULT; AGED; ANTICOAGULATION; AORTA VALVE REPLACEMENT; ARTICLE; BRAIN HEMORRHAGE; CAUSE OF DEATH; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DATA BASE; DRUG FATALITY; ENDOCARDITIS; EPISTAXIS; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEART VALVE REPLACEMENT; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REPLACEMENT; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; QUESTIONNAIRE; REOPERATION; SAINT JUDE HEART VALVE PROSTHESIS; SURGICAL MORTALITY; SURVIVAL RATE; THROMBOEMBOLISM; URINARY TRACT HEMORRHAGE;

ADULT; AGED; AGED, 80 AND OVER; AORTIC VALVE; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MINNESOTA; MITRAL VALVE;

EID: 36949029612     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Emery RW, Lindsay WU, Anderson RW, Jorgensen CR, Wang Y, Nicoloff DM. Clinical and hemodynamic results with the St. Jude Medical aortic valve prosthesis. Surg Forum 1979;30:235-238
2. Khan S, Trento A, DeRobertis M, et al. Twenty-year comparison of tissue and mechanical valve replacement. J Thorac Cardiovasc Surg 2001;122:257-269
3. Ikonomides JS, Krantz JM, Crumblely AT, et al. Twenty-year experience with the St. Jude Medical valve prosthesis. J Thorac Cardiovasc Surg 2003;126:2022-2031
4. Emery RW, Krogh CC, Arom KV, et al. The St. Jude Medical cardiac valve prosthesis: A 25-year experience with single valve replacement. Ann Thorac Surg 2005;79:776-783
5. Fessatidis I, Hackett D, Oakley CM, Sapsford RN, Bentall HH. Ten-year clinical evaluation of isolated mitral valve and double-valve replacement with the Starr-Edwards prostheses. Ann Thorac Surg 1987;43:368-372
6. Gillinov AM, Blackstone EH, Cosgrove DL, et al. Mitral valve repair with aortic valve replacement is superior to double valve replacement. J Thorac Cardiovasc Surg 2003;125:1372-1387
7. Hamamoto M, Bando K, Kobayashi J, et al. Durability and outcome of aortic valve replacement with mitral valve repair versus double valve replacement. Ann Thorac Surg 2003;75:28-34
8. Arom KV, Nicoloff DM, Kersten TE, Northrup NF, Lindsay WG, Emery RW. Ten-year follow-up study of patients who had double valve replacement with the St. Jude Medical prosthesis. J Thorac Cardiovasc Surg 1989;98:1008-1016
9. Edmunds LH, Clark RE, Cohn LH, Grunkemeier GL, Miller DL, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg 1996;62:932-935
10. Replacement Heart Valve Guidance. Office of Device Evaluation, Division of Cardiovascular, Respiratory and Neurologic Devices, Circulatory Support and Prosthetic Devices Group, US Department of Health and Human Services, Food and Drug Administration.
11. Nicoloff DM, Emery RW, Arom KV, et al. Clinical and hemodynamic results with the St. Jude Medical cardiac valve prosthesis. J Thorac Cardiovasc Surg 1982; 82:674-681
12. Cabalka AK, Emery RW, Petersen RJ, et al. Long term follow-up of the St. Jude Medical prosthesis in pediatric patients. Ann Thorac Surg 1995;60:S618-S623
13. Emery RW, Emery AM, Raikar GV, Shake JG. Anticoagulation for mechanical valve replacement: A patient-based approach. J Thrombosis Thrombolysis (in press)
14. Turpie AGG, Gent M, Laupacis A, et al. Comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med 1993;329:524-529
15. Jamieson WR, Miyagishima RT, Tyers GFO, et al. Bileaflet mechanical prosthesis in mitral and multiple valve replacement surgery: Influence of anticoagulant management on performance. Circulation 1997;96(Suppl.II):II134-II140
16. Ruel M, Masters RG, Rubens FD, et al. Late incidence and determinants of stroke after aortic and mitral valve replacement. Ann Thorac Surg 2004;78:77-84
17. Butchart EG, Ionescu A, Payne N, Giddings J, Grunkemeier GL, Fraser AG. A new scoring system to determine thromboembolic risk after heart valve replacement. Circulation 2003;108(Suppl.1):II68-II74
18. Kuwaki K, Kawagarada K, Morishita T, et al. Mitral valve repair versus replacement in simultaneous mitral and aortic valve surgery for rheumatic disease. Ann Thorac Surg 2007;83:558-563
19. Szentpetery S, Rich JB, Azar H, Newton JR, Tenzer MM. Mitral valve repair combined with aortic valve replacement. J Heart Valve Dis 1997;6:32-36
20. Koertke H, Minami K, Boethig D, et al. INR self-management permits lower anticoagulation levels after mechanical heart valve replacement. Circulation 2003;108(Suppl.1):II75-II78
21. Remadi JP, Baron O, Tribouilloy C, et al. Bivalvular mechanical mitral-aortic valve replacement in 254 patients: Long-term results - a 22-year follow-up. Ann Thorac Surg 2003;76:487-492